Home Contact Email WhatsApp

News

Together We Build the Future | Autobio at MEDICA 2024

Source:Autobio DiagnosticsTime:2024.11.14

gate.jpg

From November 11 to 14, MEDICA, the world's leading comprehensive medical exhibition, opened in Düsseldorf, Germany, attracting thousands of top medical companies from around the world and nearly 10,000 medical professionals. As a world-renowned comprehensive medical equipment exhibition, MEDICA gathers thousands of top medical companies from around the world and attracts nearly 10,000 medical professionals.

 

Autobio has been exhibiting at MEDICA for many consecutive years, and this year we focused on the AutoLumo A6200 series products. The product is an automatic luminescence immunoassay analyzer with an on-line detection speed of up to 2400T/h, featuring dual core escort, fast detection, easy to use, expanding interconnection, safety and reliability, etc. The series can be used with Autobio's AutoLumo A6200 series.

 

A6200.jpg

The series can be paired with Autobio's more than 160 magnetic particle chemiluminescence detection reagents, with a complete menu of items and a high self-sufficiency rate of core raw materials. It excels in infectious diseases, tumors, thyroid, sex hormones, respiratory pathogens, hypertension, and upgraded to autoimmune, allergens, and other emerging and leading items.

 

In addition, Autobio exhibited a number of strategic products, such as AutoLumo A1860 automatic luminescence immunoassay analyzer, Ci-120x automatic coagulation analyzer and BC60 automatic blood culture system, and also presented Autobio's intelligent total laboratory solution in the form of sand table.

 

booth.jpg

Autobio's booth attracted the attention of many visitors, and the company's international business staff actively interacted with visitors, explaining product features and sharing Autobio's intelligent laboratory solutions.

customers.png

Autobio adheres to the tenet of “Committed to the promotion and advancement of medical laboratory technology, dedicated to serving human healthcare”, emphasizes investment in innovation, enriches our product line, and further expands the international market, so as to make greater contributions to the advancement of global medical care and the health and well-being of human beings.